These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 3165438

  • 21. [Lisuride in the combination treatment of Parkinson disease].
    Jellinger K.
    Wien Med Wochenschr; 1987 Apr 30; 137(7-8):155-9. PubMed ID: 3111099
    [Abstract] [Full Text] [Related]

  • 22. Parenteral administration of lisuride in Parkinson's disease.
    Luquin MR, Obeso JA, Martínez-Lage JM, Tresguerres J, Parada J, Nieuweboer B, Dorow R, Horowski R.
    Adv Neurol; 1987 Apr 30; 45():561-8. PubMed ID: 3825733
    [No Abstract] [Full Text] [Related]

  • 23. Bromocriptine and lisuride in Parkinson disease.
    Lieberman AN, Gopinathan G, Neophytides A, Leibowitz M, Walker R, Hiesiger E.
    Ann Neurol; 1983 Jan 30; 13(1):44-7. PubMed ID: 6830164
    [Abstract] [Full Text] [Related]

  • 24. Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.
    Obeso JA, Luquin MR, Martínez-Lage JM.
    Lancet; 1986 Mar 01; 1(8479):467-70. PubMed ID: 2869209
    [Abstract] [Full Text] [Related]

  • 25. [The dopamine agonist, lisuride, in the therapy of Parkinson disease].
    Madeja UD.
    Acta Histochem Suppl; 1992 Mar 01; 42():25-31. PubMed ID: 1584973
    [Abstract] [Full Text] [Related]

  • 26. A combined regimen of subcutaneous lisuride and oral Madopar HBS in Parkinson's disease.
    Chouza C, Caamaño JL, de Medina O, Aljanati R, Scaramelli A, Romero S.
    J Neural Transm Suppl; 1988 Mar 01; 27():61-70. PubMed ID: 3042913
    [Abstract] [Full Text] [Related]

  • 27. [Is dopaminergic therapy immunologically rejuvinating? Increased interferon-gamma production with the dopaminergic agent lisuride].
    Poehlau D, Baier JE, Kovacs S, Gallati H, Suchy I, Will C, Schmutz T, Neumann HA, Przuntek H.
    Fortschr Med; 1994 Apr 30; 112(12):174-6. PubMed ID: 8200605
    [Abstract] [Full Text] [Related]

  • 28. [Continuous dopaminergic stimulation in Parkinson disease].
    Obeso JA, Luquin MR, Vaamonde J, Grandas F, Pastor MA, Artieda J, Martínez-Lage JM.
    Neurologia; 1987 Apr 30; 2(5):227-34. PubMed ID: 2908545
    [No Abstract] [Full Text] [Related]

  • 29. Pergolide and lisuride in advanced Parkinson's disease.
    Lieberman AN, Gopinathan G, Neophytides A, Leibowitz M, Goldstein M.
    Adv Neurol; 1984 Apr 30; 40():503-7. PubMed ID: 6695627
    [Abstract] [Full Text] [Related]

  • 30. [Oral lisuride in Parkinson's disease].
    Obeso JA, Luquin MR, Martínez Lage JM.
    Med Clin (Barc); 1985 Sep 21; 85(8):307-12. PubMed ID: 4068822
    [No Abstract] [Full Text] [Related]

  • 31. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist.
    Lieberman AN, Goldstein M, Neophytides A, Leibowitz M, Gopinathan G, Goodgold A, Pact V, Walker R.
    N Y State J Med; 1981 Nov 21; 81(12):1751-5. PubMed ID: 6949052
    [No Abstract] [Full Text] [Related]

  • 32. [Effect of lisuride in the "on-off" phenomena due to L-dopa].
    Piccinin GL, Piccirilli M, Rizzo PA, Agostini L.
    Clin Ter; 1983 Mar 31; 104(6):469-71. PubMed ID: 6851447
    [No Abstract] [Full Text] [Related]

  • 33. Lisuride infusion pump for Parkinson's disease.
    Lancet; 1986 May 17; 1(8490):1150-1. PubMed ID: 2871399
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [A new levodopa benserazide preparation for Parkinson's disease with motor fluctuations refractory to standard L-dopa].
    Fernández Pardal MM, Gatto E, Micheli F, Casas Parera I, Diaz S.
    Medicina (B Aires); 1991 May 17; 51(6):561-7. PubMed ID: 7476112
    [Abstract] [Full Text] [Related]

  • 38. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
    Stocchi F, Ruggieri S, Vacca L, Olanow CW.
    Brain; 2002 Sep 17; 125(Pt 9):2058-66. PubMed ID: 12183351
    [Abstract] [Full Text] [Related]

  • 39. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
    Agnoli A, Stocchi F, Carta A, Antonini A, Bragoni M, Ruggieri SA.
    Mt Sinai J Med; 1988 Jan 17; 55(1):62-6. PubMed ID: 3258057
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.